在α-synucleinopathy中皮质突触的渐进脆弱性
bioRxiv : the preprint server for biology
|June 12, 2025
概括
阿尔法同核素病理逐渐损害大脑内皮层刺激突触,影响像帕金森氏症这样的神经退行性疾病中的认知功能. 弹性机制和节省的远程突触提供了潜在的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 突触性可塑性 突触性可塑性
- 神经退行性疾病 神经退行性疾病
背景情况:
- 阿尔法-同核素 (α-syn) 聚合物是神经退行性疾病的关键病理标志,如帕金森病和勒维体痴呆症.
- 皮层α-syn病理与认知能力下降有关,这表明神经连接的破坏.
研究的目的:
- 研究α-syn病理对前额叶皮层内突触连接的渐进影响.
- 识别特定的突触类型易受或适应α-syn积累,并描述潜在的机制.
主要方法:
- 高分辨率成像 (包括电子显微镜) 来评估突触结构和密度.
- 在受影响的神经元中进行基因表达分析 (本体学),以确定分子通路.
- 神经解剖学连接映射和电生理学记录.
主要成果:
- 在α-syn聚合物附近的皮层内激发性 (VGLUT1+) 突触的渐进性损失和结构性破坏.
- 突触α-syn积累与突触损失相关;改变的基因表达表明了弹性机制.
- 层V中的脑内内 (IT) 投射神经元是脆弱的,而远程刺激性 (VGLUT2+) 突触被遗留了.
- 抑制性 (VGAT+) 突触显示晚期阶段的适度影响;受损的激发性传播在电生理学上得到证实.
结论:
- 皮层内突触是α-synucleinopathies中连接破坏的主要位置.
- 在这些疾病的进展中,突触类型的特定脆弱性和弹性机制显而易见.
- 了解这些突触变化对于开发针对α-synucleinopathies认知衰退的向治疗至关重要.
相关概念视频
Parkinson's Disease: Overview
495
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
495
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K


